-transparent.png){kind=logo}
Chronic treatment with the selective adenosine A3 receptor agonist N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide (IB-MECA) administered prior to either 10 or 20 min forebrain ischemia in gerbils resulted in improved postischemic cerebral blood circulation, survival, and neuronal preservation. Opposite effects, i.e., impaired postischemic blood flow, enhanced mortality, and extensive neuronal destruction in the hippocampus were seen when IB-MECA was given acutely. Neither adenosine A1 nor A2 receptors are involved in these actions. The data indicate that stimulation of adenosine A3 receptors may play an important role in the development of ischemic damage, and that adenosine A3 receptors may offer a new target for therapeutic interventions.
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
May 2013,
The Annals of thoracic surgery,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
April 2022,
European journal of pharmacology,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
October 1997,
Journal of leukocyte biology,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
December 2016,
Purinergic signalling,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
February 2003,
American journal of physiology. Renal physiology,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
August 2003,
American journal of physiology. Heart and circulatory physiology,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
January 2001,
Progress in medicinal chemistry,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
January 2015,
Pharmacological reviews,
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
January 2008,
Nucleic acids symposium series (2004),
D K Von Lubitz, and
R C Lin, and
P Popik, and
M F Carter, and
K A Jacobson
May 1995,
Biochemical Society transactions,
